NEW YORK, November 7, 2024 – Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and ...
Quarter Results07.11.2024 / 12:30 CET/CESTThe issuer is solely responsible for the content of this announcement.Immunic, Inc. Reports Third Quarter 2024 Financial Resultsand Provides Corporate Update– ...
People with celiac disease, lupus, type 1 diabetes, and Sjögren’s syndrome can also be at risk ... Regular follow-up with an endocrinologist is essential to monitor thyroid function and adjust ...
The main treatment for the condition is a strict gluten free diet. According to the FDA, it is safe for those with celiac disease to eat a microscopic amount of the protein, which is why many ...
In the fourth quarter of 2024, we expect to announce updated data from the VTP-300 program in ongoing clinical trials in chronic hepatitis B at AASLD – The Liver Meeting® 2024 scheduled from November ...
In irritable bowel syndrome (IBS), patients experience gastrointestinal symptoms without any visible damage to the digestive tract. Many patients with IBS believe that specific foods, like gluten or ...